Levodopa, dopamine agonist and COMT inhibitor products and the risk of impulse control disorders (ICDs) Final SmPC and PL wording agreed by PhVWP in July 2012 Doc.Ref.: CMDh PhVWP[removed]July 2012 GREEN = new text - Dopamine agonist - Document - PDFSEARCH.IO

First Page	Meta Content
	Levodopa, dopamine agonist and COMT inhibitor products and the risk of impulse control disorders (ICDs) Final SmPC and PL wording agreed by PhVWP in July 2012 Doc.Ref.: CMDh/PhVWP[removed]July 2012 GREEN = new text Add to Reading List Document Date: 2012-07-31 10:43:19 Open Document File Size: 200,71 KB Share Result on Facebook IndustryTerm inhibitor products / levodopa product / dopamine agonist product / treatment of Parkinson’s disease / food / / MedicalCondition impulse control disorders / Parkinson’s disease / Pathological gambling / / SocialTag Catecholamines Neurotransmitters Catechols Nitrobenzenes Behavioral addiction Catechol-O-methyl transferase Dopamine Hypersexuality L-DOPA Chemistry

Levodopa, dopamine agonist and COMT inhibitor products and the risk of impulse control disorders (ICDs) Final SmPC and PL wording agreed by PhVWP in July 2012 Doc.Ref.: CMDh/PhVWP[removed]July 2012 GREEN = new textAdd to Reading List